Biogen New Zealand - Latest News [Page 1]
Treatment for Spinal Muscular Atrophy Now Registered
Friday, 24 August 2018, 1:55 pm | Biogen New Zealand
First Treatment for Spinal Muscular Atrophy Now Registered in New Zealand SPINRAZA® (nusinersen) was Gazetted on August 23, 2018, by Medsafe for the treatment of 5q spinal muscular atrophy (SMA).1,2 • New treatment a first of its kind for devastating ... More >>
Tecfidera® (Dimethyl Fumarate) Funded in New Zealand
Friday, 29 January 2016, 9:37 am | Biogen New Zealand
Tecfidera® (Dimethyl Fumarate) Funded in New Zealand as a New Treatment for Relapsing Multiple Sclerosis From February 2016 New Zealand multiple sclerosis (MS) patients will soon have affordable access to an additional option for the treatment of relapsing ... More >>